Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Ipratropium Added to Tiotropium in Healthy Males
NCT02172781Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2001
- Primary completion
- Apr 2001
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium + Ipratropium with Tiotropium + Placebo (2 arms). Primary endpoint: Area under the curve of the log-transformed value of salivary secretion at Day 22. Started Jan 2001; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02172781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172781.